Author

Yidan Chen

Westlake UniversityORCID 0000-0003-3232-6403Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Yidan Chen1 paper · Chinese University of Hong Kong, Shenzhen

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Bing Xia· 1 shared Chen CheniD· 1 shared Cunqi YeiD· 1 shared Fei ZhangiD· 1 shared Hai Xin SongiD· 1 shared Mei CheniD· 1 shared Penghong SongiD· 1 shared Pinglong XuiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Bing Xia

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Oncogenic EGFR rewires STING-TBK1 immune machinery to license DNA damage tolerance

Qin Shen, Mei Chen, Yidan Chen, Qian Zhang, Qingzhe Wu, Xinyuan Yu, Fei Zhang, Shengduo Liu, Chen Chen, Cunqi Ye, Qi Zhang, Xin‐Hua Feng, Hai Xin Song, Tingbo Liang, Penghong Song, , Pinglong Xu

This study reveals that oncogenic EGFR mutations exploit the STING-TBK1 immune pathway to enhance DNA damage repair and therapeutic resistance in NSCLC.

bioRxiv · Oct 20, 2025 · PreprintCancer Biology